|
KMID : 1141720150030010005
|
|
폐쇄성폐질환
2015 Volume.3 No. 1 p.5 ~ p.5
|
|
|
|
|
Jo Kyung-Uk
Hong Sang-Bum
Shim Tae-Sun
|
|
|
Abstract
|
|
|
Lung transplantation is an established therapy for a range of end-stage pulmonary disease. Long-term outcomes, however, remains limited primarily because of the onset of bronchiolitis obliterans syndrome (BOS), which is characterized by irreversible progressive airflow limitation. This article reviews current knowledge of the pathogenesis,
incidence, diagnosis, risk factor of BOS and outlines the current practice in the treatment of this serious complication.
|
|
|
KEYWORD
|
|
|
Lung transplantation, Bronchiolitis obliterans syndrome, Rejection
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|